Inclusion program coordinator joins UC College of Engineering and Applied Science
New hire will coordinate summer bridge program and special events
Ashantia Collins
Ashantia Collins joined the University of Cincinnati College of Engineering and Applied Science department of inclusive excellence and community engagement. She will serve as the program coordinator for summer STEM bridge program and special events
In her role, Collins will manage all aspects of the summer STEM bridge program and support CEAS students, including veterans and those who identify as LGBTQ.
“I am excited to be part of the Bearcat family and I look forward to using my experiences to help ease the transition of our incoming engineering students,” Collins says.
Collins, who came to UC in December, is a Grand Rapids, Mich., native. She attended Ohio's Miami University, where she obtained a Bachelor’s degree in psychology. She also studied abroad at the University of the Arts – London where she received her master’s in psychology. Prior to joining UC, Collins worked at Michigan State University and Grand Valley State University.
Collins’ office is located in 610 Old Chemistry.
Featured image at top: A panorama of UC's campus. Photo/UC Creative Services
Related Stories
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
UC awarded nearly $1 million to help fight infant obesity spike
December 12, 2025
University of Cincinnati researcher Cathy Stough spoke with Spectrum News1 about a nearly $1 million National Institutes of Health grant awarded to UC to help prevent infant obesity through early nutrition support and family-based interventions.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.